FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971012938> ?p ?o ?g. }

• W1971012938 endingPage "139" @default.
• W1971012938 startingPage "130" @default.
• W1971012938 abstract "Background and Objectives: CIK cells are a novel population of efficient immune effector cells with high antitumour activity mainly due to the high proliferation of CD3+CD56+ cells, so may play a role in the development of new forms of adoptive cellular immunotherapy. We started a pilot clinical trial with autologous CIK cells in patients with refractory lymphoma and metastatic solid tumours. This study was aimed at determining the feasibility of generating a sufficient number of CIK cells in heavily pretreated patients and at assessing treatment toxicity. Design and Methods: CIK cells were generated from peripheral blood mononuclear cells (MNC) and incubated in the presence of IFN-γ followed by OKT3 and IL-2. Treatment schedule consisted of three cycles of CIK cells infusions at an interval of 3 weeks. Results: At present 12 patients were enrolled: 6 advanced lymphomas, 5 metastatic kidney carcinoma and 1 hepatocellular carcinoma (HCC). The median number of transferred cells per patient was 28 × 109 (range, 6–61). Protocol adherence was excellent and the toxicity profile was favourable. After CIK cells infusion, the absolute median count of lymphocytes, CD3+, CD8+ and CD3+CD56+ cells significantly increased in patient's peripheral blood. Clinical outcome appeared promising: three patients had complete response (CR) and two patients had stabilization of disease with a median follow-up of 33 months (range, 9–44). Interpretations and Conclusions: These preliminary data showed that adoptive immunotherapy with CIK cells is a safe therapy with some suggestion of efficacy that significantly enhances immune functions increasing absolute numbers of effector cells without side effects. If confirmed in larger scale studies, these promising results may have a favourable impact on conventional treatment strategy of malignancies. Copyright © 2009 John Wiley & Sons, Ltd." @default.
• W1971012938 created "2016-06-24" @default.
• W1971012938 creator A5002022076 @default.
• W1971012938 creator A5005511704 @default.
• W1971012938 creator A5013035289 @default.
• W1971012938 creator A5026007988 @default.
• W1971012938 creator A5056167540 @default.
• W1971012938 creator A5069494685 @default.
• W1971012938 date "2009-09-01" @default.
• W1971012938 modified "2023-10-14" @default.
• W1971012938 title "Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial" @default.
• W1971012938 cites W1481357784 @default.
• W1971012938 cites W1564959198 @default.
• W1971012938 cites W1983431609 @default.
• W1971012938 cites W1984519174 @default.
• W1971012938 cites W1985981664 @default.
• W1971012938 cites W1987052003 @default.
• W1971012938 cites W1990773283 @default.
• W1971012938 cites W2002807798 @default.
• W1971012938 cites W2029036039 @default.
• W1971012938 cites W2040044146 @default.
• W1971012938 cites W2046761147 @default.
• W1971012938 cites W2074735600 @default.
• W1971012938 cites W2086485522 @default.
• W1971012938 cites W2087362460 @default.
• W1971012938 cites W2089828715 @default.
• W1971012938 cites W2099657378 @default.
• W1971012938 cites W2101385118 @default.
• W1971012938 cites W2123914905 @default.
• W1971012938 cites W2133114658 @default.
• W1971012938 cites W2144751606 @default.
• W1971012938 cites W2147548158 @default.
• W1971012938 cites W2152193821 @default.
• W1971012938 cites W4236942203 @default.
• W1971012938 cites W4321835902 @default.
• W1971012938 cites W88796997 @default.
• W1971012938 doi "https://doi.org/10.1002/hon.886" @default.
• W1971012938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19294626" @default.
• W1971012938 hasPublicationYear "2009" @default.
• W1971012938 type Work @default.
• W1971012938 sameAs 1971012938 @default.
• W1971012938 citedByCount "126" @default.
• W1971012938 countsByYear W19710129382012 @default.
• W1971012938 countsByYear W19710129382013 @default.
• W1971012938 countsByYear W19710129382014 @default.
• W1971012938 countsByYear W19710129382015 @default.
• W1971012938 countsByYear W19710129382016 @default.
• W1971012938 countsByYear W19710129382017 @default.
• W1971012938 countsByYear W19710129382018 @default.
• W1971012938 countsByYear W19710129382019 @default.
• W1971012938 countsByYear W19710129382020 @default.
• W1971012938 countsByYear W19710129382021 @default.
• W1971012938 countsByYear W19710129382022 @default.
• W1971012938 countsByYear W19710129382023 @default.
• W1971012938 crossrefType "journal-article" @default.
• W1971012938 hasAuthorship W1971012938A5002022076 @default.
• W1971012938 hasAuthorship W1971012938A5005511704 @default.
• W1971012938 hasAuthorship W1971012938A5013035289 @default.
• W1971012938 hasAuthorship W1971012938A5026007988 @default.
• W1971012938 hasAuthorship W1971012938A5056167540 @default.
• W1971012938 hasAuthorship W1971012938A5069494685 @default.
• W1971012938 hasConcept C10882517 @default.
• W1971012938 hasConcept C114684123 @default.
• W1971012938 hasConcept C126322002 @default.
• W1971012938 hasConcept C137061746 @default.
• W1971012938 hasConcept C143998085 @default.
• W1971012938 hasConcept C167672396 @default.
• W1971012938 hasConcept C202751555 @default.
• W1971012938 hasConcept C203014093 @default.
• W1971012938 hasConcept C2777472916 @default.
• W1971012938 hasConcept C2777701055 @default.
• W1971012938 hasConcept C2779109515 @default.
• W1971012938 hasConcept C28328180 @default.
• W1971012938 hasConcept C2908647359 @default.
• W1971012938 hasConcept C54355233 @default.
• W1971012938 hasConcept C55493867 @default.
• W1971012938 hasConcept C71924100 @default.
• W1971012938 hasConcept C86803240 @default.
• W1971012938 hasConcept C8891405 @default.
• W1971012938 hasConcept C90924648 @default.
• W1971012938 hasConcept C99454951 @default.
• W1971012938 hasConceptScore W1971012938C10882517 @default.
• W1971012938 hasConceptScore W1971012938C114684123 @default.
• W1971012938 hasConceptScore W1971012938C126322002 @default.
• W1971012938 hasConceptScore W1971012938C137061746 @default.
• W1971012938 hasConceptScore W1971012938C143998085 @default.
• W1971012938 hasConceptScore W1971012938C167672396 @default.
• W1971012938 hasConceptScore W1971012938C202751555 @default.
• W1971012938 hasConceptScore W1971012938C203014093 @default.
• W1971012938 hasConceptScore W1971012938C2777472916 @default.
• W1971012938 hasConceptScore W1971012938C2777701055 @default.
• W1971012938 hasConceptScore W1971012938C2779109515 @default.
• W1971012938 hasConceptScore W1971012938C28328180 @default.
• W1971012938 hasConceptScore W1971012938C2908647359 @default.
• W1971012938 hasConceptScore W1971012938C54355233 @default.
• W1971012938 hasConceptScore W1971012938C55493867 @default.
• W1971012938 hasConceptScore W1971012938C71924100 @default.
• W1971012938 hasConceptScore W1971012938C86803240 @default.

• next